Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14270
Full Text
Open PDFAbstract
Available in full text
Date
August 17, 2017
Authors
Publisher
Wiley